With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
China’s obesity crisis is a sizeable profit opportunity. More than half of Chinese adults are overweight or obese — a figure expected to hit two-thirds by 2030. That is nearly 900mn people, a market ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Injectable drugs like Ozempic and Wegovy may be new to most of the world, but the science behind them are familiar to those in the health field.
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
A gene linked to obesity in Labradors is the same one found in humans, scientists say. The discovery could help researchers ...
Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
A nutritionist who lost 100 pounds using a diet he designed himself claims apples "do the exact same thing" as weight-loss ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.